The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Autoimmune diseases induced by biological agents
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
Etanercept plus Standard Therapy for Wegener's Granulomatosis
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa041884 · Cited by 834
van Oosten, B. W., Barkhof, F., Truyen, L., Boringa, J. B., Bertelsmann, F. W., von Blomberg, B. M. E., Woody, J. N., Hartung, H.-P., & Polman, C. H. (1996) · Neurology · doi:10.1212/wnl.47.6.1531 · Cited by 733
Autoimmune Diseases Induced by TNF-Targeted Therapies: Analysis of 233 Cases
Ramos-Casals, M., Brito-Zerón, P., Muñoz, S., Soria, N., Galiana, D., Bertolaccini, L., Cuadrado, M.-J., & Khamashta, M. A. (2007) · Medicine · doi:10.1097/md.0b013e3181441a68 · Cited by 733
Self-citationMaini, R. N., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Furst, D., Weisman, M. H., St.Clair, E. W., Keenan, G. F., van der Heijde, D., Marsters, P. A., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20159 · Cited by 514
Takeuchi, T., Tatsuki, Y., Nogami, Y., Ishiguro, N., Tanaka, Y., Yamanaka, H., Kamatani, N., Harigai, M., Ryu, J., Inoue, K., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.072967 · Cited by 402
De Bandt, M., Sibilia, J., Le Loët, X., Prouzeau, S., Fautrel, B., Marcelli, C., Boucquillard, E., Siame, J. L., Mariette, X., & Inflammation, T. C. R. E. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1715 · Cited by 401
Schiff, M. H., Burmester, G. R., Kent, J. D., Pangan, A. L., Kupper, H., Fitzpatrick, S. B., & Donovan, C. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.043166 · Cited by 390
Do tumor necrosis factor inhibitors cause uveitis? A registry‐based study
Lim, L. L., Fraunfelder, F. W., & Rosenbaum, J. T. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22918 · Cited by 315
Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations
Sfikakis, P. P., Markomichelakis, N., Alpsoy, E., Assaad-Khalil, S., Bodaghi, B., Gul, A., Ohno, S., Pipitone, N., Schirmer, M., Stanford, M., et al. (2007) · Rheumatology · doi:10.1093/rheumatology/kem034 · Cited by 301
Autoimmune diseases induced by TNF-targeted therapies
Ramos-Casals, M., Brito-Zerón, P., Soto, M.-J., Cuadrado, M.-J., & Khamashta, M. A. (2008) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2008.09.008 · Cited by 294
Self-citationExacerbation of ulcerative colitis after rituximab salvage therapy
Goetz, M., Atreya, R., Ghalibafian, M., Galle, P. R., & Neurath, M. F. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20215 · Cited by 268
Tumor necrosis factor‐α antagonists and neuropathy
Stübgen, J. (2008) · Muscle & Nerve · doi:10.1002/mus.20924 · Cited by 236
Williams, E. L., Gadola, S., & Edwards, C. J. (2009) · Rheumatology · doi:10.1093/rheumatology/kep080 · Cited by 207
Guillain‐Barré and Miller Fisher syndromes occurring with tumor necrosis factor α antagonist therapy
Shin, I. J., Baer, A. N., Kwon, H. J., Papadopoulos, E. J., & Siegel, J. N. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21814 · Cited by 195
Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan
KOIKE, T., HARIGAI, M., INOKUMA, S., INOUE, K., ISHIGURO, N., RYU, J., TAKEUCHI, T., TANAKA, Y., YAMANAKA, H., FUJII, K., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080791 · Cited by 179
Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves’ disease
Fassi, D. E., Nielsen, C. H., Kjeldsen, J., Clemmensen, O., & Hegedüs, L. (2008) · Gut · doi:10.1136/gut.2007.138305 · Cited by 170
A Systematic Review of the Off-Label Use of Biological Therapies in Systemic Autoimmune Diseases
Ramos‐Casals, M., Brito‐Zerón, P., Muñoz, S., & Soto, M.-J. (2008) · Medicine · doi:10.1097/md.0b013e318190f170 · Cited by 152
Self-citationWiik, A. S. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282f1331f · Cited by 111
Jonsdottir, T., Forslid, J., van Vollenhoven, A., Harju, A., Brannemark, S., Klareskog, L., & van Vollenhoven, R. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.018093 · Cited by 109
Ferraccioli, G., Mecchia, F., Poi, E. D., & Fabris, M. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.4.358 · Cited by 99
Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma
Mielke, F., Schneider-Obermeyer, J., & Dörner, T. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.080929 · Cited by 85
Development of Crohn’s disease following anti‐tumour necrosis factor therapy (etanercept)
Yazısız, V., Avci, A. B., Erbasan, F., Yıldırım, B., & Terzıoğlu, E. (2008) · Colorectal Disease · doi:10.1111/j.1463-1318.2008.01490.x · Cited by 59
New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept.
Song, I., Appel, H., Haibel, H., Loddenkemper, C., Braun, J., Sieper, J., & Rudwaleit, M. (2008) · PubMed · Cited by 54
New-onset psoriasis following treatment with the interleukin-1 receptor antagonist anakinra
González-López, M. A., Martínez-Taboada, V., Gonzaléz‐Vela, M. C., Fernández‐Llaca, H., & Val‐Bernal, J. F. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08470.x · Cited by 31
Development of Crohn disease in a patient on etanercept for psoriasis
Ahmad, K. A., & Rogers, S. N. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08009.x · Cited by 21
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Optimizing anti-TNF treatments in inflammatory bowel disease
Ben-Horin, S., Kopylov, U., & Chowers, Y. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.06.002 · Cited by 419
Psoriasis: Which therapy for which patient
Kaushik, S. B., & Lebwohl, M. G. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.06.057 · Cited by 368
The pathogenesis of systemic lupus erythematosus—an update
Choi, J., Kim, S. T., & Craft, J. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.10.004 · Cited by 360
CNS Demyelination with TNF-α Blockers
Kemanetzoglou, E., & Andreadou, E. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0742-1 · Cited by 319
Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease
Castiella, A. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i4.160 · Cited by 131
Metadata
- Authors
- Ramos-Casals, M., Roberto-Perez-Alvarez, Diaz-Lagares, C., Cuadrado, M.-J., & Khamashta, M. A.
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 9
- Issue
- 3
- Pages
- 188-193
- ISSN
- 1568-9972 (ISSN-L)
- OpenAlex
- W2177368405
- Cited by
- 323
- References
- 27
- FWCI
- 16.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.